If tumor-suppressor gene PTEN has mutated or is absent, the DNA replication process derails and can lead to cancer development, according to a new study by Wen Shen, Ph.D. Read more
Double-drug therapy may be just as effective as triple-drug therapy, with less toxicity, for some patients with transplant-ineligible multiple myeloma, according to a study by Ruben Niesvizky, M.D. Read more
Himisha Beltran, M.D., developed an 81-gene classifier that enables diagnosis of the complex and variable neuroendocrine subclass of treatment-resistant prostate cancer. Read more
The treatment landscape for individuals with chronic lymphocytic leukemia (CLL) has evolved dramatically over the past few years, according to Richard Furman, M.D. Read more
A visit to Weill gave young Algerian doctor Khaoula Mazouzi a glimpse into how multidisciplinary clinical care and translational research is conducted Read more
The Joint Clinical Trials Office has contracted with a California company to develop an electronic informed consent program for oncology patients at Weill Cornell Medical College and NewYork-Presbyterian Hospital. Read more
Engineers in Ithaca, working in conjunction with Leandro Cerchietti, M.D., have created a functional, synthetic immune organ that can convert B cells into germinal centers. Read more